GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

About 10% to 18% of people who have shingles experience what's known as postherpetic neuralgia (PHN), characterized by lasting pain at the site of the rash. People with PHN may continue to feel unwell ...

Shingles is a disease that affects your nerves. It can cause burning, shooting pain, tingling ... of getting shingles increases as you age. People may have a harder time fighting off infections ...

2 SHINGRIX is approved for the prevention of shingles (herpes zoster ... Cheng J, Rosenquist RW. Herpes zoster and postherpetic neuralgia. Fundamentals of Pain Medicine. 2018:221-5. 15. Kawai K, ...

When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...

Decades later, a declining VZV-specific host immunity [31] leads to virus reactivation, usually resulting in herpes zoster (also known as shingles ... pain—so-called postherpetic neuralgia ...

For 20 years, doctors told Diana Falzone her pain was normal. “Well, that’s just how it is for some women,” she remembers one ...

A review by the American College of Physicians (ACP) of performance measures designed to evaluate quality of care for those ...

“These challenges are really drawing people in who have that psychological affinity — sensation-seeking, reward-seeking types of behaviors,” Elisa Trucco, director of the Research on ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

“No pain, no gain.” That’s what Trivariate Research, a U.S. equity-focused research house, said about stocks that have exploded at least 900% over a 5-year trading period. There have been 20 ...